Abstract
Although frailty status is dynamic, whether improvements in frailty predict mortality is unknown. Describe 1-year changes in a frailty index (FI) and association with 48-month mortality. Secondary analysis of the National Health in Aging Trends Study. Community. Five thousand six hundred and seventy two Medicare beneficiaries 65 and older (3,267 (55.8%) females). A 40-item deficit accumulation FI was measured in 2011 and 2012, based on multidomain assessment including comorbidities, activities of daily living, physical tasks, cognition, and performance testing. We categorized 2011 FI into robust (FI < 0.15), pre-frail (FI = 0.15-0.24), mild frailty (FI = 0.25-0.34), and moderate to severe frailty (FI ≥ 0.35). Change in frailty was calculated as the FI change from 2011 to 2012, categorized as either absolute (>0.045 decrease, 0.015-0.045 decrease, ±0.015 change, 0.015-0.045 increase, >0.045 increase) or proportional change (>20% decrease, 5-20% decrease, ±5% change, 5-20% increase, 20% increase). We measured the association of FI change with 4-year mortality using Cox regression. From 2011 to 2012, mean FI increased by 0.02 (standard deviation 0.07), with 58.6% having an increase. Over 4 years, 1,039 participants (13.6%) died. After adjusting for age and sex, compared to stable frailty (±0.015), both absolute (>0.045) and proportional (>20%) increases in frailty were associated with higher mortality among pre-frail participants (hazard ratio (HR) = 2.35, 95% confidence interval (CI) = (1.45-3.79) and HR (95% CI) = 3.32 (1.76-6.26), respectively), participants with mild frailty (HR (95% CI) = 1.96 (1.35-2.85) and 2.03 (1.37-3.02)) and moderate or severe frailty (HR (95% CI) = 1.99 (1.48-2.67) and 1.94 (1.43-2.63)) but not robust participants (HR (95% CI)= 1.48 (0.86-2.54), HR (95% CI) = 1.62 (0.80-3.28)). However, decreases in FI were not significantly associated with decreased risk of mortality. Increasing deficit accumulation FI over 1 year is associated with increased mortality risk. While decreasing FI occurs, we did not find evidence to support reduced mortality risk.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.